BRIEF-Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in US – Reuters
|
BRIEF-Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in US
Reuters BRIEF-Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in US. March 8 Celyad SA: * Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA Source text for Eikon: Further company coverage: (Gdynia … |
